Recent Updates
Recently added Catalysts
ABBV Positive Sentiment Score: 70/100

AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference

Monday, January 5, 2026 1 min read
Key Takeaway: AbbVie is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. The management will engage in a fireside chat at 10:15 a.m. Central time, which will be available via a live audio webcast. An archived version of the session will also be accessible later that day.
Price reaction · baseline $229.31 (2026-01-02 close) · hit pre-market · 1 other ABBV headline(s) in the window, move may be shared
day 0 close · peak
-4%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbbVie will showcase its innovations at a prominent healthcare conference.
  • The presentation highlights AbbVie's commitment to addressing health challenges.
  • Live audio webcast allows for broader access to the company's insights.

Full Press Release Details

NORTH CHICAGO, Ill.,Jan. 5, 2026/PRNewswire/ -- AbbVie (NYSE:ABBV) will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. Management will participate in a fireside chat at 10:15 a.m. Central time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website atinvestors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie onLinkedIn,Facebook,Instagram,X (formerly Twitter), and YouTube.
Media:Gabby Tarbert(224) 244-0111[email protected] Investors:Liz Shea(847) 935-2211[email protected]

Frequently Asked Questions

When will AbbVie present at the conference?

AbbVie will present on January 14, 2026.

What time is AbbVie's presentation scheduled?

The presentation is scheduled for 10:15 a.m. Central time.

Where can I access the presentation webcast?

The live audio webcast will be available on AbbVie's Investor Relations website.

Will there be an archived version of the presentation?

Yes, an archived edition will be available later that day.

Tags: ABBV Viatris Investor Conferences Healthcare AbbVie J.P. Morgan Healthcare Conference healthcare investor relations biopharma
Last updated: Jan 5, 2026

Biotech snapshot

Cash runway
$9391M liquidity · $0M/mo burn
Low dilution risk
Lead asset
MGdPhase 3
Metastatic Cancer →

Catalyst track record

+32%
best trade around ABBV's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for ABBV.

See every catalyst's timing & PoA →